Currently, platelet-poor plasma (PPP) is a discarded waste product of platelet-rich plasma (PRP) and may contain valuable proteins.
Purpose/Hypothesis:
The study’s goal was to evaluate the concentration of plasma as a potential additive biotherapy for the treatment of osteoarthritis. We hypothesized that a novel polyacrylamide concentration device would efficiently concentrate insulin-like growth factor–1 (IGF-1) from PPP and be additive to PRP or autologous protein solution (APS).
Study Design:
Descriptive laboratory study.
Methods:
A laboratory study was conducted with human and equine whole blood from healthy volunteers/donors. Fresh samples of blood and plasma were processed and characterized for platelet, white blood cell, and growth factor/cytokine content and then quantified by enzyme-linked immunosorbent assays specific for IGF-1, transforming growth factor–β, interleukin-1β, and interleukin-1 receptor antagonist as representatives of cartilage anabolic and inflammatory mediators.
Results:
A potent cartilage anabolic protein, IGF-1, was significantly concentrated by the polyacrylamide concentration device in both human and equine PPP. The polyacrylamide device also substantially increased plasma proteins over whole blood, most dramatically key proteins relevant to the treatment of osteoarthritis, including transforming growth factor–β (29-fold over blood) and interleukin-1 receptor antagonist (70-fold over plasma).
Conclusion:
Concentrated PPP is a unique source for biologically relevant concentrations of IGF-1. PRP and APS can produce greater concentrations of other anabolic and anti-inflammatory proteins not found in plasma.
Clinical Relevance:
The polyacrylamide device efficiently concentrated PPP to create a unique source of IGF-1 that may supplement orthopaedic biologic therapies.
AnituaEAndiaIArdanzaBNurdenPNurdenAT.Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2003;91(1):4-15.
2.
BansalHComellaKLeonJet al. Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis. J Transl Med. 2017;15(1):141.
3.
BennellKLHunterDJPatersonKL.Platelet-rich plasma for the management of hip and knee osteoarthritis. Curr Rheumatol Rep. 2017;19(5):24.
4.
BertoneALIshiharaAZekasLJet al. Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses. Am J Vet Res. 2014;75(2):141-151.
5.
ColeBJKarasBHusseyKPilzKFortierLA.Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med. 2017;45(2):339-346.
6.
CrossJAColeBJSpatnyKPet al. Leukocyte-reduced platelet-rich plasma normalizes matrix metabolism in torn human rotator cuff tendons. Am J Sports Med. 2015;43(12):2898-2906.
7.
CucchiariniMMadryH.Overexpression of human IGF-1 via direct rAAV-mediated gene transfer improves the early repair of articular cartilage defects in vivo. Gene Ther. 2014;21:811-819.
8.
DuifCBogelTTopcuogluFSpyrouGvon Schulze PellengahrCLahnerM.Does intraoperative application of leukocyte-poor platelet-rich plasma during arthroscopy for knee degeneration affect postoperative pain function and quality of life? A 12-month randomized controlled double-blind trial. Arch Orthop Trauma Surg. 2015;135(7):971-977.
9.
FawzyRMHashaadNIMansourAI.Decrease of serum biomarker of type II collagen degradation (Coll2-1) by intra-articular injection of an autologous plasma-rich-platelet in patients with unilateral primary knee osteoarthritis. Eur J Rheumatol. 2017;4(2):93-97.
10.
FortierLADeakMMSemevolosSACerioneRA.Insulin-like growth factor-I diminishes the activation status and expression of the small GTPase Cdc42 in articular chondrocytes. J Orthop Res. 2004;22:436-445.
11.
FortierLAMohammedHOLustGNixonAJ.Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br. 2002;84:276-288.
12.
FrisbieD.Autologous-conditioned serum: evidence for use in the knee. J Knee Surg. 2015;28(1):63-66.
13.
GoodrichLRHidakaCRobbinsPDEvansCHNixconAJ.Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br. 2007;89:672-685.
14.
GrafeIAlexanderSPetersonJRet al. TGF-β family signaling in mesenchymal differentiation. Cold Spring Harb Perspect Biol. 2018;10(5):A022202.
15.
GugjooMBAmarpal, Abdelbaset-IsmailAet al. Mesenchymal stem cells with IGF-1 and TGF-β1 in laminin gel for osteochondral defects in rabbits. Biomed Pharmacother. 2017;93:1165-1174.
16.
HauptJLFrisbieDDMcIlwraithCWet al. Dual transduction of insulin-like growth factor-I and interleukin-l receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model. J Orthop Res. 2005;23(1):118-126.
17.
HemphillDDMcIlwraithCWSlaydenRASamulskiRJGoodrichLR.Adeno-associated virus gene therapy vector scAAVIGF-1 for transduction of equine articular chondrocytes and RNA-seq analysis. Osteoarthritis Cartilage. 2016;24(5):902-911.
18.
HixJKlaassenMForemanRet al. An autologous anti-inflammatory protein solution yielded a favorable safety profile and signifiant pain relief in an open-label pilot study of patients with osteoarthritis. Biores Open Access. 2017;6(1):151-158.
19.
HuangP-HWangC-JChouW-YWangJ-WKoJ-Y.Short-term clinical results of intra-articular PRP injections for early osteoarthritis of the knee. Int J Surg. 2017;42:117-122.
20.
IkedaYSakaueMChijimatsuRet al. IGF-1 gene transfer to human synovial MSCs promotes their chondrogenic differentiation potential without induction of the hypertrophic phenotype. Stem Cells Int. 2017;2017:5804147.
21.
IonitaCRTroilletARVahlenkampTWWinterKBrehmWIonitaJ-C.Comparison of humoral insulin-like growth factor-1, platelet-derived growth factor-BB, transforming growth factor-β1, and interleukin-1 receptor antagonist concentrations among equine autologous blood-derived preparations. Am J Vet Res. 2016;77(8):898-905.
22.
JinRShenMYuLWangXLinX.Adipose-derived stem cells suppress inflammation induced by IL-1beta through down-regulation of P2X7R mediated by miR-373 in chondrocytes of osteoarthritis. Mol Cells. 2017;40(3):222-229.
23.
Joshi JubertNRodriguezLReverte-VinaixaMMNavarroA.Platelet-rich plasma injections for advanced knee osteoarthritis: a prospective, randomized, double-blind clinical trial. Orthop J Sports Med. 2017;5(2):2325967116689386.
24.
KingWBendeleAMarohlTWoodell-MayJ.Human blood-based anti-inflammatory solution inhibits osteoarthritis progression in a meniscal-tear rat study. J Orthop Res. 2017;35(10):2260-2268.
25.
KingWvan der WeegenWVan DrumptRSoonsHTolerKWoodell-MayJ.White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution. J Exp Orthop. 2016;3(1):9.
26.
KisidayJDMcIlwraithCWRodkeyWGFrisbieDDSteadmanJR.Effects of platelet-rich plasma composition on anabolic and catabolic activities in equine cartilage and meniscal explants. Cartilage. 2012;3(3):245-254.
27.
KonEEngebetsenLVerdonkPNehrerSFilardoG.Clinical outcomes of knee osteoarthritis treated with an autologous protein solution injection: a 1-year pilot double-blinded randomized controlled trial. Am J Sports Med. 2019;46(1):171-180.
28.
LongobardiLO’RearLAakulaSet al. Effect of IGF-1 in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TF-B signaling. J Bone Miner Res. 2006;21(4):626-636.
29.
MadryHKaulGCucchiariniMet al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor 1. Gene Ther. 2005;12:1171-1179.
30.
MadryHKaulGZurakowskiDVunjak-NovakovicGCucchiariniM.Cartilage constructs engineered from chondrocytes overexpressing IGF-1 improve the repair of osteochondral defects in a rabbit model. Eur Cell Mater. 2013;25:229-247.
31.
MakkiMSHaqqiTM.Histone deacetylase inhibitor vorinostat (SAHA) suppresses IL-1β–induced matrix metallopeptidase-13 expression by inhibiting IL-6 in osteoarthritis chondrocyte. Am J Pathol. 2016;186(10):2701-2708.
32.
MatuskaAO’shaughnesseyKKingWWoodell-MayJ.Autologous solution protects bovine cartilage explants from IL-1a- and TNFa-induced cartilage degradation. J Orthop Res. 2013;31(12):1929-1935.
NgVYJumpSSSantangeloKSRussellDSBertoneAL.Genetic engineering of juvenile human chondrocytes improves scaffold-free mosaic neocartilage grafts. Clin Orthop Relat Res. 2013;471(1):26-38.
35.
OrtvedKFBegumLMohammedHONixonAJ.Implantation of rAAV5-IGF-1 transduced autologous chondrocytes improves cartilage repair in full-thickness defects in the equine model. Mol Ther. 2015;23:363-373.
36.
O’ShaughnesseyKMatuskaAHoeppnerJet al. Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors. J Orthop Res. 2014;32(10):1349-1355.
37.
Osiecka-IwanAMoskalewskiSHycA.Influence of IGF1, TGFβ1, bFGF and G-CSF/M-CSF on the mRNA levels of selected matrix proteins, cytokines, metalloproteinase 3 and TIMP1 in rat synovial membrane cells. Folia Histochem Cytobiol. 2016;54(3):159-165.
38.
PasoldJZanderKHeskampBet al. Positive impact of IGF-1 coupled nanoparticles on the differentiation potential of human chondrocytes cultured on collagen scaffolds. Int J Nanomed. 2015;10:1131-1143.
39.
SeifarthCCsakiCShakibaeiM.Anabolic actions of IGF-1 and TGF-beta 1 on interleukin-1beta-treated human articular chondrocytes: evaluation in two and three dimensional cultures. Histol Histopathol. 2009;24(10):1245-1262.
40.
ShireSJShahrokhZLiuJ.Challenges in the development of high protein concentration formulations. J Pharm Sci. 2004;93(6):1390-1402.
41.
Simental-MendíaMVílchez-CavazosJFPeña-MartínezVMSaid-FernándezSLara-AriasJMartínez-RodríguezHG.Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Arch Orthop Trauma Surg. 2016;136(12):1723-1732.
42.
SundmanEAColeBJKarasVet al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med. 2014;42(1):35-41.
43.
SutterWWKanepsAJBertoneAL.Comparison of hematologic values and transforming growth factor-beta and insulin-like growth factor concentrations in platelet concentrates obtained by use of buffy coat and apheresis methods from equine blood. Am J Vet Res. 2004;65(7):924-930.
44.
TeschGAHandleyCJCornellHJHeringtonAC.Effects of free and bound insulin-like growth factors on proteoglycan metabolism in articular cartilage explants. J Orthop Res. 1992;10:14-22.
45.
TextorJATablinF.Intra-articular use of a platelet-rich product in normal horses: clinical signs and cytologic responses. Vet Surg. 2013;42(5):499-510.
46.
TongSLiuJZhangC.Platelet-rich plasma inhibits inflammatory factors and represses rheumatoid fibroblast-like synoviocytes in rheumatoid arthritis. Clin Exp Med. 2017;17(4):441-449.
47.
TuliRTuliSNandiSet al. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem. 2003;278(42):41227-41236.
48.
UchimuraTGooteATSmithELMatzkinEFZengL.Insulin-like growth factor II (IGF-II) inhibits IL-1b-induced cartilage matrix loss and promotes cartilage integrity in experimental osteoarthritis. J Cell Biochem. 2015;116(12):2858-2869.
49.
WangXLuoYMasciPPCrawfordRXiaoY.Influence of interleukin-1 beta on platelet-poor plasma clot formation: a potential impact on early bone healing. PLoS One. 2016;11(2):e0149775.
50.
WanstrathAWHettlichBFSuLet al. Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in a canine population. Vet Surg. 2016;45(6):764-774.
51.
Woodell-MayJMatuskaAOysterMWelchZO’ShaughnesseyKHoeppnerJ.Autologous protein solution inhibits MMP-13 production by IL-1β and TNFα-stimulated human articular chondrocytes. J Orthop Res. 2011;29(9):1320-1326.
52.
YangJLuYGuoA.Platelet-rich plasma protects rat chondrocytes from interleukin-1β-induced apoptosis. Mol Med Rep. 2016;14(5):4075-4082.
53.
ZhangZLiLYangWet al. The effects of different doses of IGF-1 on cartilage and subchondral bone during the repair of full-thickness articular cartilage defects in rabbits. Osteoarthritis Cartilage. 2017;25:309-320.
54.
ZhouQLiBZhaoJPanWXuJChenS.IGF-I induces adipose derived mesenchymal cell chondrogenic differentiation in vitro and enhances chondrogenesis in vivo. In Vitro Cell Dev Biol Anim. 2016;52(3):356-364.
